Published

Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuropharmacology
Date: 2015-12-01
Source: Crossref
DOI: 10.1016/j.neuropharm.2015.07.018
PubMed: 26192543

Authors

Spain Aisling Howarth Clare Khrapitchev Alexandre A.Sharp Trevor Sibson Nicola R.Martin Chris

Watch author

Derived topics and classifications

psilocin Brain Imaging Receptor Pharmacology Aging Animal Study Animal Study

Citation graph

40 referenced DOIs found in stored source metadata. 3 indexed papers cite this DOI.

Open citation network

10.1016/j.neuropharm.2011.01.015 10.1523/jneurosci.5015-08.2009 10.1016/j.neuroimage.2004.08.011 10.1523/jneurosci.6063-09.2010 10.1038/nrd2027 10.1007/bf01062336 10.1016/j.neuron.2007.11.008 10.1073/pnas.1119598109 10.1192/bjp.bp.111.103309 10.1523/jneurosci.3065-04.2004 10.1016/s0301-0082(96)00033-0 10.1007/bf00401509

Indexed papers citing this DOI

Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors2026-03-26 Acute psilocin increased cortical activity in rat2026-02-04 Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain2015-12-01

Related papers

Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging StudyClinicalTrials.gov · 2025-08-20 Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot StudyClinicalTrials.gov · 2026-06-23 Psilocybin-Assisted Therapy for Prolonged GriefClinicalTrials.gov · 2026-06-23 Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging TrialClinicalTrials.gov · 2026-03-24 Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic TherapiesClinicalTrials.gov · 2026-03-20 Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinomaCancer Research · 2024-01-15 PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under PsilocybinScientific Data · 2026-05-21